Post-approval studies (Phase 4)Study completedNCT01378117
What this trial is testing
Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes
Who this might be right for
Type 2 Diabetes MellitusHospitalizationHyperglycemia
Emory University 90